Smith Nicholas Conrad's Form 4 filing
Alto Neuroscience, Inc. (ANRO) · filed Feb 7, 2024
- Accession no.
- 0001415889-24-002940
- Filed
- Feb 7, 2024
- Trade date
- Feb 6, 2024
- Filing delay
- 1 day
- Rule 10b5-1 plan
- Not checked
This filing lists 1 non-derivative transaction and 0 derivative transactions. Open-market purchases total $25.0K. It was filed 1 day after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Smith Nicholas ConradCIK 0002009130 | Officer (CHIEF FINANCIAL OFFICER) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Feb 6, 2024 | Common Stock | PPurchaseAcquired | +1,563 | $16.00 | +$25,008 | 1,563 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.